Related Experiment Video
Updated: May 28, 2026
11:02
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
Direct mutation analysis by high-throughput sequencing: from germline to low-abundant, somatic variants
1Albert Einstein College of Medicine, Department of Genetics, New York, NY 10461, United States.
Mutation Research
|October 22, 2011
Summary
Massively parallel sequencing (MPS) has revolutionized mutation analysis by reducing costs and enabling whole genome sequencing. However, detecting low-abundance mutations remains a challenge for understanding genetic variation and diseases like cancer.
Area of Science:
- Genetics
- Genomics
- Molecular Biology
Background:
- DNA mutations drive genetic variation, with deleterious mutations causing disease in humans.
- Cancer arises from mutations and selection in somatic cells.
- Rapid advancements in sequencing technology have transformed mutation analysis.
Purpose of the Study:
- To review the history and classical tools of mutation rate measurement.
- To discuss the impact of massively parallel sequencing (MPS) on mutation frequency and spectra analysis.
- To highlight limitations and future directions in mutation detection.
Main Methods:
- Review of historical mutation research methods.
- Analysis of massively parallel sequencing (MPS) applications.
- Examination of whole genome sequencing data for mutation frequency and spectra.
Main Results:
- MPS has significantly reduced sequencing costs, enabling whole genome sequencing.
- Direct estimates of germline mutation rates are now feasible.
- Current MPS methods struggle to detect low-abundance somatic mutations.
Conclusions:
- MPS has greatly advanced mutation analysis, providing new insights into mutation frequencies.
- Detecting low-abundance somatic mutations is crucial for understanding intra-tumor heterogeneity and other diseases.
- Emerging sequencing platforms promise further progress in mutation detection.
